ZERACTO Trademark

Trademark Overview

On Friday, September 28, 2018, a trademark application was filed for ZERACTO with the United States Patent and Trademark Office. The USPTO has given the ZERACTO trademark a serial number of 79245986. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 26, 2019. This trademark is owned by INFECTOPHARM Arzneimittel und ConsiliumGmbH. The ZERACTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, dermatological products, excluding all pharmaceutical preparation for the treatment of blood diseases and disorders
zeracto

General Information

Serial Number79245986
Word MarkZERACTO
Filing DateFriday, September 28, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, August 26, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical products, namely, dermatological products, excluding all pharmaceutical preparation for the treatment of blood diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 26, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINFECTOPHARM Arzneimittel und ConsiliumGmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Saturday, September 26, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, September 5, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, August 26, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, May 8, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, April 22, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 22, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, March 6, 2020LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, February 7, 2020LIMITATION OF GOODS RECEIVED FROM IB
Monday, August 26, 2019ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, August 26, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, June 28, 2019ATTORNEY REVIEW COMPLETED
Friday, June 21, 2019LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Friday, April 12, 2019LIMITATION OF GOODS RECEIVED FROM IB
Saturday, February 16, 2019REFUSAL PROCESSED BY IB
Sunday, January 27, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, January 26, 2019REFUSAL PROCESSED BY MPU
Tuesday, January 15, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 14, 2019NON-FINAL ACTION WRITTEN
Wednesday, January 9, 2019ASSIGNED TO EXAMINER
Friday, November 30, 2018APPLICATION FILING RECEIPT MAILED
Monday, November 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 22, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zeracto pharmaceutical products blood disorders treatment diseases excluding namely dermatological preparation